J. Correia de Sá

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

T. Ziemssen, N. Tubridy, J. Frederiksen, 2014, Journal of Neurology.

REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal

J. Cerqueira, S. Batista, L. Sousa, 2020, Neurological Sciences.

Consensus for the Early Identification of Secondary Progressive Multiple Sclerosis in Portugal: a Delphi Panel.

L. Sousa, Irene Mendes, A. Morganho, 2023, Acta medica portuguesa.

Multifocal central and peripheral demyelination associated with hepatitis C virus infection

J. Pimentel, T. Mestre, J. Correia de Sá, 2007, Journal of Neurology.